SwineCast Industry

How Are Compatible Antigens for Swine Vaccines Created?

Utilization of Modern Scientific Technologies to Produce Compatible Antigens for Swine VaccinesProducing Compatible Antigens for Swine Vaccines Dr. Jeff Galvin, Zoetis, presents on utilizing modern scientific technologies to produce compatible antigens for swine vaccines. Dr. Galvin highlights the path to finding vaccines that fit the need to protect against both porcine circovirus type 2 (PCV2) and mycoplasma hyopneumoniae [video].

Developing Swine Vaccine Licenses

Porcine Epidemic Diarrhea virus (PEDv) Vaccine, Path to Conditional LicensePath to Conditional License Dr. Meggan Bandrick, Clinical Research Veterinarian, Zoetis; and Postdoctoral Veterinary Research Scientist, USDA-National Animal Disease Center, talks about how a conditional license for a porcine epidemic diarrhea virus (PEDv) vaccine was developed. Dr. Bandrick shares the studies that were designed and the steps needed to develop data to support the license. Dr. Bandrick concludes with information on developing a fully licensed PEDv vaccine [video].

How Is Your Biosurveillance?

Evolution of BiosurveillanceEvolution of Biosurveillance Drs. Jeff Zimmerman & Rodger Main, Iowa State University, look at the evolution of biosurveillance. Drs. Zimmerman & Main both state there needs to be data to help support multiple types of surveillance. Today the swine ecosystem has an unprecedented opportunity to create effective surveillance systems [video].

Can DNA Shuffling Offer Path To PRRSv Vaccine?

Designing PRRSV Vaccines for Heterologous ProtectionDesigning PRRSV Vaccines for Heterologous Protection Dr. X.J. Meng, VA-MD College of Veterinary Medicine, Virginia Tech, looks at designing Porcine Reproductive and Respiratory Syndrome Virus (PRRSv) vaccine for heterologous protection. Dr. Meng states that PRRS remains a major problem to the global swine industry. Dr. Meng also mentions there is an emergence of new and more virulent PRRSv strains, like “porcine high fever disease” caused by a highly pathogenic PRRSv. A conclusion from developing a PRRSv vaccine: DNA shuffling offers an opportunity for rational design of PRRSv MLV vaccines that confer heterologous protection [video].

Keynote: Evolution And Change

Evolution And Change: Preparing For TomorrowSwine Farm Preparing For Tomorrow Glenn Stolt, Christensen Farms CEO, and Jeff Rusch, Christensen Farms Vice President of Production, Health and Nutrition, walk through the pork operations of Christensen Farms and their extensions into retail food product creation. To get to where they are today, Christensen Farms grew through acquisition and hiring talent. Glenn and Jeff also review inflection points in the last 6 years, including the difficult times of the pork business and environment. Glenn and Jeff wrap up the conversation with their view of the future into 2020 [video].
Syndicate content